Pubblicazioni

Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease

2020 - THE ONCOLOGIST

Ali, S.; Moreau, A.; Melchiorri, D.; Camarero, J.; Josephson, F.; Olimpier, O.; Bergh, J.; Karres, D.; Tzogani, K.; Gisselbrecht, C.; Pignatti, F.

Identification of New Soluble Factors Correlated With the Development of Graft Failure After Haploidentical Hematopoietic Stem Cell Transplantation

2020 - FRONTIERS IN IMMUNOLOGY

Weber, G.; Strocchio, L.; Del Bufalo, F.; Algeri, M.; Pagliara, D.; Arnone, C. M.; De Angelis, B.; Quintarelli, C.; Locatelli, F.; Merli, P.; Caruana, I.